HYFXY yields 116182.10% · JNJ yields 2.13%● Live data
📍 HYFXY pulled ahead of the other in Year 1
Combined, HYFXY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of HYFXY + JNJ for your $10,000?
Hyflux Ltd provides various solutions in water and energy areas worldwide. The company operates through two segments, Municipal and Industrial. The Municipal segment supplies a range of infrastructure solutions, including water, power, and waste-to-energy to municipalities and governments. The Industrial segment supplies infrastructure solutions for water to industrial customers. The company provides seawater desalination, raw water purification, wastewater cleaning, water recycling, water reclamation, and pure water production services to municipal and industrial clients, as well as to home consumers; and filtration and purification products. It also designs, constructs, owns, operates, and sells water treatment, seawater desalination, wastewater treatment, and water recycling plants under service concession arrangements; and sells oxygen-rich water and related products and services. In addition, the company designs, constructs, owns, operates, and sells power plants and waste-to-energy plants; trades in the electricity markets; and sells retail electricity contracts. Hyflux Ltd was founded in 1989 and is headquartered in Singapore.
Full HYFXY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.